SERUM ERYTHROPOIETIN CONCENTRATIONS AND IRON STATUS IN PATIENTS ON CHRONIC-HEMODIALYSIS

被引:0
|
作者
SEGUCHI, C
SHIMA, T
MISAKI, M
TAKARADA, Y
OKAZAKI, T
机构
[1] MIE UNIV,SCH MED,DEPT INTERNAL MED 3,TSU,MIE 514,JAPAN
[2] MIE UNIV,CTR STUDENT HLTH,TSU,MIE 514,JAPAN
[3] NATL TSU HOSP,HISAI,MIE 51411,JAPAN
关键词
IRON-BINDING CAPACITY; FERRITIN; ANEMIA; RADIOIMMUNOASSAY; CHRONIC RENAL FAILURE;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We studied the relationship between serum erythropoietin (EPO) concentration and iron status in 67 patients undergoing chronic hemodialysis. Serum concentrations of EPO were measured by RIA with recombinant human EPO. The geometric mean of the serum EPO concentration was 10.9 int. units/L (mean +/- SD range = 7.8 - 15.3 int. units/L) in hemodialysis patients, considerably lower than that in normal subjects (12.9 int. units/L). We found no significant correlation between concentrations of serum EPO and hemoglobin in hemodialysis patients, but found a significant negative correlation between serum concentrations of EPO and iron in hemodialysis patients. Moreover, we also found a significant positive correlation between the EPO concentration and the unsaturated iron-binding capacity (UIBC) in serum, and a significant negative correlation between the serum concentrations of EPO and ferritin in hemodialysis patients. Several patients who had relatively high EPO concentrations for hemodialysis patients also had low iron concentrations, high UIBC values, and low ferritin concentrations. These findings suggest that iron was utilized even at these EPO concentrations, which were very low for the degree of anemia observed in the hemodialysis patients.
引用
收藏
页码:199 / 203
页数:5
相关论文
共 50 条
  • [1] ELEVATION OF SERUM ERYTHROPOIETIN AFTER SUBTOTAL PARATHYROIDECTOMY IN CHRONIC-HEMODIALYSIS PATIENTS
    WASHIO, M
    ISEKI, K
    ONOYAMA, K
    OH, Y
    NAKAMOTO, M
    FUJIMI, S
    FUJISHIMA, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (02) : 121 - 124
  • [2] HUMAN RECOMBINANT ERYTHROPOIETIN IN CHRONIC-HEMODIALYSIS PATIENTS
    JALIL, R
    VACCAREZZA, A
    JARA, A
    LIRA, P
    VIAL, S
    SERRANO, V
    REVISTA MEDICA DE CHILE, 1990, 118 (06) : 629 - 634
  • [3] SERUM FERRITIN AS A GUIDE FOR IRON STORES IN CHRONIC-HEMODIALYSIS PATIENTS
    VANDEVYVER, FL
    VANHEULE, AA
    MAJELYNE, WM
    DHAESE, P
    BLOCKX, PP
    BEKAERT, AB
    BUYSSENS, N
    DEKEERSMAECKER, W
    DEBROE, ME
    KIDNEY INTERNATIONAL, 1984, 26 (04) : 451 - 458
  • [4] SERUM FERRITIN AND IRON-DEFICIENCY IN PATIENTS ON CHRONIC-HEMODIALYSIS
    BEALLO, R
    DALLMAN, PR
    SCHOENFELD, PY
    HUMPHREYS, MH
    TRANSACTIONS AMERICAN SOCIETY FOR ARTIFICIAL INTERNAL ORGANS, 1976, 22 : 73 - 79
  • [5] IRON STATUS IN CHRONIC-HEMODIALYSIS PATIENTS - TREATMENT OF TRANSFUSIONAL IRON OVERLOAD WITH DESFERRIOXAMINE
    MCGONIGLE, RJS
    KEOGH, AM
    WESTON, MJ
    PARSONS, V
    CROFTS, MAJ
    DIALYSIS & TRANSPLANTATION, 1984, 13 (04) : 214 - &
  • [6] SERUM FERRITIN IN PATIENTS ON CHRONIC-HEMODIALYSIS
    PATERSON, AD
    GRAIL, A
    ANASTASSIADES, E
    PLATTS, MM
    HANCOCK, BW
    CLINICAL SCIENCE, 1980, 59 (03) : P10 - P10
  • [7] FUNCTIONAL STATUS IN CHRONIC-HEMODIALYSIS PATIENTS
    JONES, KR
    DIALYSIS & TRANSPLANTATION, 1990, 19 (04) : 173 - &
  • [8] SERUM FERRITIN AS AN INDEX OF BODY IRON STORES IN PATIENTS ON CHRONIC-HEMODIALYSIS
    CRASWELL, P
    HUNT, F
    DAVIES, L
    RUSSO, A
    GOETHART, J
    HALLIDAY, J
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1978, 8 (01): : 38 - 42
  • [9] PHARMACOKINETICS OF RECOMBINANT HUMAN ERYTHROPOIETIN IN CHRONIC-HEMODIALYSIS PATIENTS
    NIELSEN, OJ
    PHARMACOLOGY & TOXICOLOGY, 1990, 66 (02): : 83 - 86
  • [10] EFFECT OF ERYTHROPOIETIN ON SYMPATHETIC TONE IN CHRONIC-HEMODIALYSIS PATIENTS
    FRITSCHKA, E
    NEUMAYER, HH
    SEDDIGHI, S
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 368 - 368